Applying artificial intelligence to decode the microbiome in Parkinson's disease
The composition of the microbiome plays a key role in Parkinson’s disease (PD). Artificial intelligence-based analysis of metagenomic data reveals predictive microbial signatures.
Challenge
The client needed an accurate model to analyze microbiome data from PD patients and identify bacterial taxa linked to the disease.
Approach
- Processed stool samples from PD patients and healthy controls.
- Applied machine learning to extract impactful microbial signatures.
Results
- Developed a high-accuracy model outperforming competitors.
- Identified key bacterial taxa influencing PD predictions.
AI-based microbiome analysis is providing new insights into Parkinson’s disease, supporting early detection and targeted therapies.
Expert Contribution
Reviewed by:Dr. Krzysztof Kolmus, PhD
Role: Lead Bioinformatician, AI‑Driven Drug Discovery
Expertise: Biomarker discovery, target identification, multi‑omics data analysis, translational bioinformatics
